Canada markets open in 9 hours 3 minutes

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0141+0.0005 (+3.68%)
At close: 03:51PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
52,979
52,979
-76,698
-205,192
-142,309
Depreciation & amortization
1,781
1,781
2,046
1,023
302
Stock based compensation
1,189
1,189
3,313
8,898
12,697
Change in working capital
4,728
4,728
6,018
10,578
-15,227
Accounts receivable
-4,612
-4,612
5,323
-5,382
-1,067
Inventory
2,106
2,106
1,566
-21
-6,010
Accounts Payable
4,090
4,090
4,474
-4
4,126
Other working capital
-8,972
-8,972
-70,751
-149,606
-107,083
Other non-cash items
1,804
1,804
3,243
4,069
2,940
Net cash provided by operating activites
-8,968
-8,968
-70,410
-146,667
-104,829
Cash flows from investing activities
Investments in property, plant and equipment
-4
-4
-341
-2,939
-2,254
Purchases of investments
-
-
-
-
0
Sales/Maturities of investments
-
-
0
0
8,233
Net cash used for investing activites
-4
-4
-341
-2,689
6,229
Cash flows from financing activities
Debt repayment
-1,154
-1,154
-5,892
0
0
Common stock issued
0
0
32,320
81,534
107,519
Common stock repurchased
0
0
-18
0
-
Other financing activites
-
-
-1,202
-1,297
-3,742
Net cash used privided by (used for) financing activities
4,776
4,776
61,939
90,693
154,226
Net change in cash
-4,196
-4,196
-8,812
-58,663
55,626
Cash at beginning of period
4,776
4,776
13,588
72,251
16,625
Cash at end of period
580
580
4,776
13,588
72,251
Free Cash Flow
Operating Cash Flow
-8,968
-8,968
-70,410
-146,667
-104,829
Capital Expenditure
-4
-4
-341
-2,939
-2,254
Free Cash Flow
-8,972
-8,972
-70,751
-149,606
-107,083